EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model

Kazuhiro Okumura, Takao Morinaga, Megumi Saito, Yurika Tokunaga, Keisuke Otoyama, Sora Tanaka, Eriko Isogai, Masahito Kawazu, Yosuke Togashi iD, Yoshinori Hasegawa, Yuichi Wakabayashi iD

Cancer Science · 2024

DOI: 10.1111/cas.16246 ↗

At a glance

Journal article in Cancer Science, 2024. Written by Kazuhiro Okumura and 10 co-authors. Institution: Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan. Major MEDLINE topics: p21-Activated Kinases, Skin Neoplasms, Carcinoma, Squamous Cell, Disease Models, Animal. Cited 2 times so far (Crossref); 17 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Japan Society for the Promotion of Science, Takeda Foundation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

By taking advantage of forward genetic analysis in mice, we have demonstrated that Pak1 plays a crucial role during DMBA/TPA skin carcinogenesis. Although Pak1 has been considered to promote cancer development, its overall function remains poorly understood. To clarify the functional significance of Pak1 in detail, we sought to evaluate the possible effect of an allosteric inhibitor against PAK1 (NVS‐PAK1‐1) on a syngeneic mouse model. To this end, we established two cell lines, 9AS1 and 19AS1, derived from DMBA/TPA‐induced squamous cell carcinoma (SCC) that engrafted in FVB mice. Based on our present results, NVS‐PAK1‐1 treatment significantly inhibited the growth of tumors derived from 9AS1 and 19AS1 cells in vitro and in vivo. RNA‐sequencing analysis on the engrafted tumors indicates that NVS‐PAK1‐1 markedly potentiates the epidermal cell differentiation and enhances the immune response in the engrafted tumors. Consistent with these observations, we found an expansion of Pan‐keratin‐positive regions and potentially elevated infiltration of CD8‐positive immune cells in NVS‐PAK1‐1‐treated tumors as examined by immunohistochemical analyses. Together, our present findings strongly suggest that PAK1 is tightly linked to the development of SCC, and that its inhibition is a promising therapeutic strategy against SCC.

Subjects

MeSH terms (MEDLINE)

p21-Activated KinasesSkin NeoplasmsCarcinoma, Squamous CellDisease Models, AnimalAnimalsMiceCell Line, Tumor9,10-Dimethyl-1,2-benzanthraceneFemaleCell DifferentiationTetradecanoylphorbol AcetateCD8-Positive T-LymphocytesCell Proliferation

Author keywords

DMBA/TPAPAK1 inhibitormousesquamous cell carcinomasyngenic model

Substances

p21-Activated KinasesPak1 protein, mouse9,10-Dimethyl-1,2-benzanthraceneTetradecanoylphorbol Acetate

Authors and institutions

  • Division of Experimental Animal Research, Cancer Genome Center, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Division of Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Department of Tumor Microenvironment, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.

ORCID profiles: Yosuke Togashi, Yuichi Wakabayashi

Funding

  • Japan Society for the Promotion of Science
  • Takeda Foundation

Cite

APA

Okumura, K., Morinaga, T., Saito, M., Tokunaga, Y., Otoyama, K., Tanaka, S., Isogai, E., Kawazu, M., Togashi, Y., Hasegawa, Y., & Wakabayashi, Y. (2024). Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer Science. https://doi.org/10.1111/cas.16246

Vancouver

Okumura K, Morinaga T, Saito M, Tokunaga Y, Otoyama K, Tanaka S, et al. Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model. Cancer Science. 2024. doi:10.1111/cas.16246

BibTeX
@article{Okumura2024,
  author = {Okumura, Kazuhiro and Morinaga, Takao and Saito, Megumi and Tokunaga, Yurika and Otoyama, Keisuke and Tanaka, Sora and Isogai, Eriko and Kawazu, Masahito and Togashi, Yosuke and Hasegawa, Yoshinori and Wakabayashi, Yuichi},
  title = {Targeting PAK1 is effective against cutaneous squamous cell carcinoma in a syngenic mouse model},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16246}
}
Start for free →